Sugi Predict
/ Targets
/ MYADM
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
Clinical trials — most relevant to MYADM by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
| Centocor Microarray Study of Patients |
PHASE4 | COMPLETED |
| Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia |
PHASE2 | COMPLETED |
| Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia |
PHASE1/PHASE2 | COMPLETED |
| Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML |
PHASE1/PHASE2 | COMPLETED |
| A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia |
PHASE2 | COMPLETED |
| Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers |
PHASE2 | COMPLETED |
| IRon Nanoparticle Enhanced MRI in the Assessment of Myocardial infarctioN |
PHASE2 | COMPLETED |
| Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms |
PHASE1/PHASE2 | RECRUITING |
| Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute |
nan | UNKNOWN |
| Postprandial Monocyte Study |
nan | COMPLETED |
| Kinetics of INF-γ Production in Intensive Care Patients |
nan | RECRUITING |
| Corticosteroid Prophylaxis on the Cardiopulmonary Bypass-Induced Systemic Inflammatory Response |
nan | COMPLETED |
| Detection of Circulating Biomarkers of Immunogenic Cell Death |
nan | COMPLETED |
| Prognostic Value of CD318 in AML at Assiut University Hospital. |
nan | UNKNOWN |
| Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome |
nan | COMPLETED |
| Study of Trans-tissular Migration of Macrophages Associated to Human Breast Cancer |
nan | UNKNOWN |
| Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches |
nan | ACTIVE_NOT_RECRUITING |
| Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM) |
nan | RECRUITING |
| Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia |
nan | UNKNOWN |
| Myeloid Derived Suppressor Cells and Chronic Myeloid Leukemia |
nan | UNKNOWN |
| Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes |
nan | COMPLETED |
| S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin |
nan | COMPLETED |
| Calprotectin, a Biomarker of COVID-19 Severity (CALPRO) |
nan | WITHDRAWN |
| Development and Prospective Validation of a Standardized Flow Cytometric Assay of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes. |
nan | UNKNOWN |
| Monocyte Phenotypic Changes in Heart Failure |
nan | COMPLETED |
| Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition. |
nan | RECRUITING |
| The Myeloid Neoplasms Biology and Outcome Project |
nan | RECRUITING |
| Pilot Study to Establish a Repertoire of Megakaryocyte Markers, Quantifiable by Spectral Flow Cytometry, in Bone Marrow and Circulating in Patients Undergoing Cardiac Surgery for Bypass Grafting |
nan | NOT_YET_RECRUITING |
| A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia |
nan | RECRUITING |
| Immunophenotyping and Xist Gene in AML |
nan | UNKNOWN |
Related proteins — ESM-2 sequence neighbours (a MYADM binder may also engage these)